AI is reshaping the food industry, engineering hyper-palatable foods that override hunger signals and manipulate cravings. Is ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using ...

People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide) and Mounjaro ...

North Carolina is facing a $500 million dollar problem. State officials say the state is running out of money to pay for the ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

The assassination of UnitedHealthcare CEO Brian Thompson triggered a disturbing avalanche of sympathy for the suspected ...

The pharma giant will now offer 7.5mg and 10mg dosages of Zepbound, as well as lower rates for its 2.5mg and 5mg vials.

Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound.